Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic fields to stimulate specific areas of the brain. It was first developed in 1985 and has since gained popularity as a technique used by neuroscientists and clinicians. TMS holds tremendous potential for advancing our understanding of brain function and treating several neurological and psychiatric conditions. This article explores the working, applications, benefits and limitations of TMS.
How does TMS work?
TMS works on the principle of electromagnetic induction. It uses brief magnetic field pulses generated by an electromagnet to induce weak electric currents in the brain without requiring surgery. The magnetic pulses are generated by passing electrical current through a tightly wound coil of wire that is placed on the scalp above the targeted brain region. The magnetic pulses penetrate the scalp and skull to reach very focal areas of the cerebral cortex, about 1-2 cm deep.
The electric currents are strong enough to depolarize neurons and cause them to fire. Repeated pulses of Transcranial magnetic stimulation can increase or decrease cortical excitability lasting from minutes to hours after stimulation depending on the parameters used. This allows localized and non-invasive manipulation of brain areas in a painless manner.
Advancing brain mapping
One of the major applications of TMS is in brain mapping, which allows neuroscientists to understand functional localization in the brain. For example, stimulating the motor cortex with TMS elicits muscle twitches in specific body parts due to its somatotopic organization. This forms the basis of using TMS to precisely map motor areas controlling different parts of the body. Similarly, stimulating Broca's and Wernicke's areas involved in language elicits speech errors or disruptions, helping neurologists map these language centers. Such cortical mapping helps treat tumors, vascular malformations or epilepsy surgery near critical brain areas.
TMS can also reveal connections between distant but linked brain regions. For example, stimulating the visual cortex produces phosphenes or visual flashes as the signal travels along the visual pathway. Combining TMS with techniques like functional Magnetic Resonance Imaging (fMRI) and electroencephalography (EEG) provides insights into how stimulation of one area alters activity in connected regions remotely, improving our understanding of brain networks. While invasive methods like cortical stimulation can also map connections, TMS offers a painless alternative.
Treating neurological and psychiatric conditions
Repetitive TMS (rTMS) has gained FDA approval for treating medication-resistant major depressive disorder. Evidence shows rTMS targeted at the left dorsolateral prefrontal cortex produces antidepressant effects comparable to medications, lasting several weeks. This non-invasive option is beneficial for patients who don't respond well or cannot tolerate side effects of antidepressants. Studies are examining the potential of rTMS as an augmenting therapy when combined with medications.
Low-frequency rTMS over the motor cortex has been found effective at reducing migraine frequency and intensity when given as a preventive treatment. Researchers think it works by modulating pain processing in connected areas like the trigeminal nerve pathway. TMS is also being explored for reducing chronic pain like fibromyalgia, neuropathic pain, osteoarthritis and lower back pain with varying degrees of success depending on the area targeted and stimulation parameters used.
Subheading: Improving motor function post-stroke
High-frequency rTMS or paired associative stimulation when targeted at the unaffected motor cortex contralateral to the affected limb has shown promise in improving motor function and limb control after strokes involving the corticospinal tract. The stimulation is believed to enhance excitability and induce neuroplastic changes in the affected motor networks to aid recovery. Larger trials are studying TMS as an adjuvant to physical and occupational therapy post-stroke.
Limitations and the road ahead
While TMS has great potential, limitations remain. The effects are focal and stimulating deeper sub-cortical structures is challenging. Long term effects beyond 1-2 months still require better understanding. TMS protocols need refining to optimize therapeutic efficacy. Combined with other techniques and adjunctive therapies, next-generation TMS coils offering even better spatial resolution and more personalized stimulation parameters hold promise to take this novel neuroscience tool even further as an invaluable research instrument and clinical intervention. Overall, transcranial magnetic stimulation opened exciting new vistas for non-invasive study and treatment of the mind and brain.
Get More Insights Here
https://coolbio.org/monoclonal-antibody-therapeutics-revolutionizing-patient-care/
